BRAVE: A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia (clinicaltrials.gov) - Oct 3, 2026 - P3 | N=255 | Active, not recruiting | Sponsor: Biogen | Recruiting ➔ Active, not recruiting
Enrollment closed • Ataxia • Friedreich ataxia • Movement Disorders
|